250 related articles for article (PubMed ID: 29662478)
1. BALB/c and C57BL/6 Mice Cytokine Responses to
Ferreira BL; Ferreira ÉR; de Brito MV; Salu BR; Oliva MLV; Mortara RA; Orikaza CM
Front Microbiol; 2018; 9():553. PubMed ID: 29662478
[No Abstract] [Full Text] [Related]
2. Phenotypic, functional and serological aspects of genotypic-specific immune response of experimental T. cruzi infection.
da Silveira-Lemos D; Alessio GD; Batista MA; de Azevedo PO; Reis-Cunha JL; Mendes TAO; Lourdes RA; de Lana M; Fujiwara RT; Filho OAM; Bartholomeu DC
Acta Trop; 2021 Oct; 222():106021. PubMed ID: 34161815
[TBL] [Abstract][Full Text] [Related]
3. Differential susceptibility to acute Trypanosoma cruzi infection in BALB/c and C57BL/6 mice is not associated with a distinct parasite load but cytokine abnormalities.
Roggero E; Perez A; Tamae-Kakazu M; Piazzon I; Nepomnaschy I; Wietzerbin J; Serra E; Revelli S; Bottasso O
Clin Exp Immunol; 2002 Jun; 128(3):421-8. PubMed ID: 12067296
[TBL] [Abstract][Full Text] [Related]
4. Chronic murine Chagas' disease: the impact of host and parasite genotypes.
Andersson J; Orn A; Sunnemark D
Immunol Lett; 2003 Apr; 86(2):207-12. PubMed ID: 12644324
[TBL] [Abstract][Full Text] [Related]
5.
Barbosa CG; Carvalho Costa TM; Desidério CS; Ferreira PTM; Silva MO; Hernández CG; Santos MM; Trevisan RO; Bovi WG; Rodrigues V; Machado JR; Ramirez LE; de Oliveira CJF; da Silva MV
Mediators Inflamm; 2019; 2019():7214798. PubMed ID: 31636507
[TBL] [Abstract][Full Text] [Related]
6. Trypanosoma cruzi: role of host genetic background in the differential tissue distribution of parasite clonal populations.
Andrade LO; Machado CR; Chiari E; Pena SD; Macedo AM
Exp Parasitol; 2002 Apr; 100(4):269-75. PubMed ID: 12128054
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-9 in Immunopathology of
Silva NSL; Orikaza CM; de Santana FR; Dos Santos LA; Salu BR; Oliva MLV; Sinigaglia RC; Mortara RA
Front Cell Infect Microbiol; 2021; 11():756521. PubMed ID: 34722343
[TBL] [Abstract][Full Text] [Related]
8. Predicting Blood Parasite Load and Influence of Expression of iNOS on the Effect Size of Clinical Laboratory Parameters in Acute
Rodrigues WF; Miguel CB; Marques LC; da Costa TA; de Abreu MCM; Oliveira CJF; Lazo-Chica JE
Front Immunol; 2022; 13():850037. PubMed ID: 35371021
[TBL] [Abstract][Full Text] [Related]
9. [TH1 response in the experimental infection with Trypanosoma cruzi].
Cardoni RL; Antúnez MI; Abrami AA
Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
[TBL] [Abstract][Full Text] [Related]
10. Indeterminate Chagas' disease: Trypanosoma cruzi strain and re-infection are factors involved in the progression of cardiopathy.
Bustamante JM; Rivarola HW; Fernández AR; Enders JE; Fretes R; Palma JA; Paglini-Oliva PA
Clin Sci (Lond); 2003 Apr; 104(4):415-20. PubMed ID: 12653687
[TBL] [Abstract][Full Text] [Related]
11. CD8
Mateus J; Nocua P; Lasso P; López MC; Thomas MC; Egui A; Cuervo C; González JM; Puerta CJ; Cuéllar A
Front Cell Infect Microbiol; 2021; 11():723121. PubMed ID: 34712620
[TBL] [Abstract][Full Text] [Related]
12. Host Genetics Background Influence in the Intragastric
Domingues CS; Cardoso FO; Hardoim DJ; Pelajo-Machado M; Bertho AL; Calabrese KDS
Front Immunol; 2020; 11():566476. PubMed ID: 33329529
[TBL] [Abstract][Full Text] [Related]
13. Performance of TcI/TcVI/TcII Chagas-Flow ATE-IgG2a for universal and genotype-specific serodiagnosis of Trypanosoma cruzi infection.
Alessio GD; de Araújo FF; Côrtes DF; Sales Júnior PA; Lima DC; Gomes MS; do Amaral LR; Xavier MA; Teixeira-Carvalho A; Martins-Filho OA; de Lana M
PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005444. PubMed ID: 28333926
[TBL] [Abstract][Full Text] [Related]
14. TcI, TcII and TcVI Trypanosoma cruzi samples from Chagas disease patients with distinct clinical forms and critical analysis of in vitro and in vivo behavior, response to treatment and infection evolution in murine model.
Oliveira MT; Branquinho RT; Alessio GD; Mello CGC; Nogueira-de-Paiva NC; Carneiro CM; Toledo MJO; Reis AB; Martins-Filho OAM; Lana M
Acta Trop; 2017 Mar; 167():108-120. PubMed ID: 27908747
[TBL] [Abstract][Full Text] [Related]
15. Trypanosoma cruzi trans-sialidase: enhancement of virulence in a murine model of Chagas' disease.
Chuenkova M; Pereira ME
J Exp Med; 1995 May; 181(5):1693-703. PubMed ID: 7722448
[TBL] [Abstract][Full Text] [Related]
16. Endogenous CD4(+) CD25(+) regulatory T cells have a limited role in the control of Trypanosoma cruzi infection in mice.
Kotner J; Tarleton R
Infect Immun; 2007 Feb; 75(2):861-9. PubMed ID: 17101658
[TBL] [Abstract][Full Text] [Related]
17. Microbiome Alterations Driven by
Castañeda S; Muñoz M; Hotez PJ; Bottazzi ME; Paniz-Mondolfi AE; Jones KM; Mejia R; Poveda C; Ramírez JD
Microbiol Spectr; 2023 Jun; 11(3):e0019923. PubMed ID: 37140369
[TBL] [Abstract][Full Text] [Related]
18. Modulation of STAT-1, STAT-3, and STAT-6 activities in THP-1 derived macrophages infected with two
Oliveira MM; Bonturi CR; Salu BR; Oliva MLV; Mortara RA; Orikaza CM
Front Immunol; 2022; 13():1038332. PubMed ID: 36389843
[No Abstract] [Full Text] [Related]
19. Increased susceptibility of Fas ligand-deficient gld mice to Trypanosoma cruzi infection due to a Th2-biased host immune response.
Lopes MF; Nunes MP; Henriques-Pons A; Giese N; Morse HC; Davidson WF; Araújo-Jorge TC; DosReis GA
Eur J Immunol; 1999 Jan; 29(1):81-9. PubMed ID: 9933089
[TBL] [Abstract][Full Text] [Related]
20. Trypanosoma cruzi: acute infection affects expression of alpha-2-macroglobulin and A2MR/LRP receptor differently in C3H and C57BL/6 mice.
Soeiro Mde N; Paiva MM; Waghabi MC; Meirelles Mde N; Lorent K; Henriques-Pons A; Coutinho CM; Van Leuven F; Araújo-Jorge TC
Exp Parasitol; 2000 Oct; 96(2):97-107. PubMed ID: 11052868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
